{"id":"https://openalex.org/W6986604353","doi":null,"title":"PRODUCTION OF LENTIVIRUS PARTICLES PSEUDOTYPED WITH SARS-COV-2 SPIKE PROTEIN FOR NEUTRALISATION OR DRUG ANTIVIRAL ACTIVITY ASSAYS","display_name":"PRODUCTION OF LENTIVIRUS PARTICLES PSEUDOTYPED WITH SARS-COV-2 SPIKE PROTEIN FOR NEUTRALISATION OR DRUG ANTIVIRAL ACTIVITY ASSAYS","publication_year":2023,"publication_date":"2023-12-06","ids":{"openalex":"https://openalex.org/W6986604353"},"language":"en","primary_location":{"id":"pmh:oai:ojs2.journal.ohrm.bba.md:article/657","doi":null,"is_oa":true,"landing_page_url":"https://journal.ohrm.bba.md/index.php/index/article/view/657","pdf_url":null,"source":{"id":"https://openalex.org/S4210170215","display_name":"One Health & Risk Management","issn_l":"2587-3458","issn":["2587-3458","2587-3466"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/I4405266629","host_organization_name":"Asociatia de Biosiguranta si Biosecuritate din Republica Moldova","host_organization_lineage":["https://openalex.org/I4405266629"],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2587-3458","raw_type":"info:eu-repo/semantics/article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://journal.ohrm.bba.md/index.php/index/article/view/657","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010614976","display_name":"Mariana Ulinici","orcid":"https://orcid.org/0000-0002-9292-0124","observed_orcids":["https://orcid.org/0000-0002-9292-0124"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Mariana Ulinici","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5010614976"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.34949207,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.6904000043869019,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.6904000043869019,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.29660001397132874,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lentiviral-vectors","display_name":"lentiviral vectors","score":0.8220000267028809},{"id":"https://openalex.org/keywords/pseudotyping","display_name":"pseudotyping","score":0.6700000166893005},{"id":"https://openalex.org/keywords/sars-cov-2-spike-protein","display_name":"SARS-CoV-2 spike protein","score":0.9980000257492065},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.7720000147819519}],"concepts":[{"id":"https://openalex.org/C14086860","wikidata":"https://www.wikidata.org/wiki/Q337120","display_name":"Neutralization","level":3,"score":0.6984999775886536},{"id":"https://openalex.org/C2779690655","wikidata":"https://www.wikidata.org/wiki/Q374232","display_name":"Lentivirus","level":4,"score":0.6906999945640564},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5892000198364258},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5371999740600586},{"id":"https://openalex.org/C2781390188","wikidata":"https://www.wikidata.org/wiki/Q25203449","display_name":"Spike (software development)","level":2,"score":0.47589999437332153},{"id":"https://openalex.org/C2909509916","wikidata":"https://www.wikidata.org/wiki/Q22329850","display_name":"Spike Protein","level":5,"score":0.4413999915122986},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4131999909877777},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.398499995470047},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.373199999332428},{"id":"https://openalex.org/C2779756493","wikidata":"https://www.wikidata.org/wiki/Q846227","display_name":"Antiviral drug","level":3,"score":0.3441999852657318},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.31850001215934753},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.3009999990463257},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.30059999227523804},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2883000075817108},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.2752000093460083},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2517000138759613}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:ojs2.journal.ohrm.bba.md:article/657","doi":null,"is_oa":true,"landing_page_url":"https://journal.ohrm.bba.md/index.php/index/article/view/657","pdf_url":null,"source":{"id":"https://openalex.org/S4210170215","display_name":"One Health & Risk Management","issn_l":"2587-3458","issn":["2587-3458","2587-3466"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/I4405266629","host_organization_name":"Asociatia de Biosiguranta si Biosecuritate din Republica Moldova","host_organization_lineage":["https://openalex.org/I4405266629"],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2587-3458","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:https://cyberleninka.ru/article/n/production-of-lentivirus-particles-pseudotyped-with-sars-cov-2-spike-protein-for-neutralisation-or-drug-antiviral-activity-assays","doi":null,"is_oa":false,"landing_page_url":"https://cyberleninka.ru/article/n/production-of-lentivirus-particles-pseudotyped-with-sars-cov-2-spike-protein-for-neutralisation-or-drug-antiviral-activity-assays","pdf_url":null,"source":{"id":"https://openalex.org/S4306401404","display_name":"CyberLeninK (CyberLeninka)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"text"},{"id":"pmh:oai:ibn.idsi.md:192295","doi":null,"is_oa":true,"landing_page_url":"https://ibn.idsi.md/vizualizare_articol/192295","pdf_url":null,"source":null,"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"One Health and Risk Management S_Rez (2) 77-77","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:ojs2.journal.ohrm.bba.md:article/657","doi":null,"is_oa":true,"landing_page_url":"https://journal.ohrm.bba.md/index.php/index/article/view/657","pdf_url":null,"source":{"id":"https://openalex.org/S4210170215","display_name":"One Health & Risk Management","issn_l":"2587-3458","issn":["2587-3458","2587-3466"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/I4405266629","host_organization_name":"Asociatia de Biosiguranta si Biosecuritate din Republica Moldova","host_organization_lineage":["https://openalex.org/I4405266629"],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2587-3458","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.6240000128746033,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3111144189","https://openalex.org/W3128885880","https://openalex.org/W3020828664","https://openalex.org/W3215808480","https://openalex.org/W3184989518","https://openalex.org/W3097451149","https://openalex.org/W7018483576","https://openalex.org/W7042609318","https://openalex.org/W4388880064","https://openalex.org/W6976632101"],"abstract_inverted_index":{"Introduction.":[0],"Lentivirus":[1,199],"particles":[2,30,50,67,95,239,332,429],"are":[3],"commonly":[4],"employed":[5],"as":[6,202,461,463],"gene":[7,110],"delivery":[8],"vectors":[9],"due":[10],"to":[11,14,28,47,64,92,147,362,371,390,416,452,464],"their":[12,40],"ability":[13,43,415],"transduce":[15],"both":[16,212],"dividing":[17],"and":[18,84,120,217,253,265,282,388,442],"non-dividing":[19],"cells":[20,273,419],"efficiently.":[21],"Lately,":[22],"there":[23],"have":[24],"been":[25,45,369],"alterations":[26],"made":[27],"lentivirus":[29,49,66,94,158,161,177,223,238,262,331,410,428],"so":[31],"that":[32],"they":[33],"can":[34,210,224],"express":[35],"heterologous":[36],"envelope":[37,167],"proteins":[38,187],"on":[39,232,300,424],"surface.":[41],"This":[42,307,366],"has":[44,368],"exploited":[46],"produce":[48,65,93],"pseudotyped":[51,68,96,240,333,430],"with":[52,69,97,170,188,241,274,319,334,400,431],"the":[53,61,70,108,112,124,128,157,171,176,181,185,189,194,233,237,242,249,343,348,352,358,363,373,385,392,397,401,408,421,425,454],"SARS-CoV-2":[54,71,98,178,222,243,290,335,409,432,460],"Spike":[55,72,99,186,244,336,433],"glycoprotein.":[56,100],"Aim.":[57],"The":[58,101,135,197,261,330,379,405,427],"aim":[59],"of":[60,156,206,277,304,313,326,351,407,456],"study":[62,341,438],"was":[63,90,141,168,200,309,411],"glycoprotein":[73,130,245,337,434],"for":[74,107,118,127,139,175,184,193,445,468],"use":[75],"in":[76,339,376,436],"neutralisation":[77,446],"or":[78,447],"drug":[79,448],"antiviral":[80,449],"activity":[81,450],"assays.":[82],"Material":[83],"methods.":[85],"A":[86],"second-generation":[87],"HIV-LV":[88],"system":[89],"used":[91,174,201],"lentiviral":[102],"transfer":[103],"plasmid":[104,115,122,136,182,190],"plVTHM":[105],"encoding":[106,117,126,138,192],"reporter":[109],"eGFP,":[111],"HIV":[113],"packaging":[114],"psPAX2":[116],"gag-pol,":[119],"a":[121,160,203,293,324,440],"carrying":[123],"sequence":[125,137],"structure":[129],"Spike,":[131],"pcDNA3-SARS-CoV-2-Spike-D614G\u039419,":[132],"were":[133,246,267],"used.":[134],"eGFP":[140],"flanked":[142],"by":[143,269,287,347,396,413],"long":[144],"terminal":[145],"repeats":[146],"facilitate":[148],"host":[149],"genome":[150],"integration.":[151],"To":[152],"ensure":[153],"controlled":[154],"transduction":[155,207],"SARS-CoV-2,":[159,266],"expressing":[162,229,420],"Vesicular":[163],"Stomatitis":[164],"Virus":[165],"(VSV)":[166],"produced":[169,338,435],"same":[172],"protocol":[173],"but":[179],"replacing":[180],"coding":[183],"pMD2.G":[191],"VSV":[195,198,264,320],"envelope.":[196],"positive":[204],"control":[205],"since":[208],"it":[209],"infect":[211,225,417],"cell":[213],"lines":[214],"HEK":[215,218,227,271],"293-ACE2":[216,272],"293.":[219],"In":[220],"contrast,":[221],"only":[226,418],"293":[228],"ACE2":[230,422],"receptor":[231,423],"membrane.":[234,426],"After":[235],"transduction,":[236],"harvested":[247],"from":[248],"culture":[250],"medium,":[251],"purified":[252],"stored":[254],"at":[255,357,384],"-80\u00b0C":[256],"until":[257],"further":[258],"use.":[259],"Results.":[260],"preparations,":[263],"titred":[268],"transducing":[270],"200":[275],"\u00b5l":[276],"2-fold":[278],"viral":[279,305,402],"preparation":[280,291],"dilutions":[281],"analysed":[283],"after":[284],"72":[285],"hours":[286],"flow":[288],"cytometry.":[289],"had":[292],"titer":[294,308,325],"around":[295,327],"~105":[296],"TU/ml":[297],"(average":[298],"measured":[299],"5":[301],"independent":[302],"experiments":[303],"preparation).":[306],"about":[310],"one":[311],"order":[312],"magnitude":[314],"lower":[315],"than":[316],"those":[317],"achieved":[318],"lentivirus,":[321],"which":[322],"obtained":[323],"~106":[328],"TU/ml.":[329],"this":[340,437],"carried":[342],"mutation":[344],"D614G":[345],"accompanied":[346],"deletion":[349,380],"(\u039419)":[350],"last":[353],"19":[354],"amino":[355],"acids":[356],"C-terminal":[359],"domain,":[360],"corresponding":[361],"ER-retention":[364],"motif.":[365],"variant":[367],"demonstrated":[370,412],"increase":[372],"pseudotyping":[374],"efficiency":[375],"several":[377],"studies.":[378],"region":[381,387],"is":[382],"located":[383],"cytoplasmic":[386,398],"appears":[389],"remove":[391],"steric":[393],"interference":[394],"given":[395],"tail":[399],"capsid.":[403],"Conclusions.":[404],"specificity":[406],"its":[414],"provide":[439],"specific":[441],"efficient":[443],"tool":[444],"assays":[451],"evaluate":[453],"efficacy":[455],"potential":[457,466],"treatments":[458],"against":[459],"well":[462],"identify":[465],"therapeutics":[467],"COVID-19.":[469]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2025-10-10T00:00:00"}